Thomas Reiser: A Great Opportunity to Advance the Field of Thrombosis and Hemostasis
Thomas Reiser, Former Executive Director at the International Society on Thrombosis and Haemostasis, reposted from ISTH on LinkedIn:
”A great opportunity to lead and further evolve a truly impactful international medical-scientific organization and work closely with an amazingly committed board and immensely talented staff team to advance the field of thrombosis and hemostasis and benefit the bleeding and clotting community around the world.”
Quoting International Society on Thrombosis and Haemostasis (ISTH)‘s post:
”We have officially launched our search for our next Executive Director.
If you are interested, please find more details at the link below.
Or if you know someone who might be interested, please pass the news along.”
Stay updated with Hemostasis Today.
-
May 27, 2026, 04:47Daniel Torrent: The Overlooked Epidemic of Post-Thrombotic Syndrome
-
May 27, 2026, 04:45Graziella Pompei: Is Aspirin Still a Valid Alternative to Clopidogrel in PCI with DES Implantation?
-
May 27, 2026, 04:40Kausik Ray: Phase 1 Trial Highlights Anti-Inflammatory Effects of Ruvonoflast
-
May 27, 2026, 04:29Francisco Chacón-Lozsán: High-Sensitivity Troponin and the Evolving Management of NSTEMI
-
May 27, 2026, 04:14Michael R. Jaff: HI-PEITHO Trial and NEWS Score Insights on Advances for Intermediate-Risk Pulmonary Embolism
-
May 26, 2026, 16:45Ashley George: Take the Leap for Thrombosis UK
-
May 26, 2026, 16:40Hamed Helisaz: Machine Learning for Detecting Missing Heart Medications
-
May 26, 2026, 15:32Haroun Gajraj: Brown Marks After Microsclerotherapy – What Every Practitioner Needs to Know
-
May 26, 2026, 15:29Jacqueline van Paassen: Lack of Essential Clinical Data in DOAC Prescriptions in Community Pharmacies